Novo Nordisk Faces Turbulent Board Shakeup as Weight-Loss Drug Market Pressures Intensify
Novo Nordisk Shareholders Approve Major Board Overhaul Novo Nordisk has entered a decisive new chapter after shareholders approved a sweeping
Adding {{itemName}} to cart
Added {{itemName}} to cart
